Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease

This study has been terminated.
(Lack of Efficacy)
Sponsor:
Information provided by:
EMD Serono
ClinicalTrials.gov Identifier:
NCT00304252
First received: March 14, 2006
Last updated: August 4, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2003
  Estimated Primary Completion Date: No date given
No publications provided by EMD Serono

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):